Phonetic and Orthographic Computer Analysis (POCA) is a technology used by the U.S. Food and Drug Administration (FDA) to evaluate proposed drug names for their potential of confusion with existing names. Watch on SERION now offers POCA scoring to help trademark professionals prioritize watch results.

In this case study, Bruce Longbottom, Senior Trademark Counsel for Eli Lilly and Company, explains why the innovative integration of POCA scoring in Watch on SERION offers a powerful, new tool for accelerating the process of assessing potential trademark infringements.